Friday, July 1, 2022
wellness India Expo
Home Tags Premas Biotech

Tag: Premas Biotech

Premas Biotech appoints Saumen Chakraborty to its Board

Saumen Chakraborty is the Managing Director of Samarjita Management Consultancy. He retired as the President and Chief Financial Officer of Dr Reddy’s in 2020

Digitally powered smart labs are the future of biopharma R&D: Experts

Leading biopharmaceutical scientists and industry leaders shared their valuable insights at the e-Conference on ‘Digital Laboratories: The Emerging Era of High-Tech R&D’ organized by BioVoice News on March 30, 2022

Premas Biotech gets approval to initiate phase 1 trials in South...

Premas Biotech has licensing deal for virus-like particle (VLP) injectable vaccine technology for COVID-19, with Oravax for commercialization in India..................

Premas Biotech & Oramed announce oral COVID-19 vaccine candidate that produces...

With triple antigen targeting, the vaccine is claimed to offer better protection against COVID-19 variants. While Oravax Medical Inc has been established to accelerate the vaccine’s path to market, clinical trials are expected to commence in Q2 2021......................

Premas Biotech’s COVID-19 vaccine shows encouraging results, human trials shortly

Triple-antigen COVID-19 vaccine candidate, PRAK-03202, produces neutralizing immune response in animal studies; Premas Biotech in talks with regulatory authorities for next steps................

Premas Biotech SARS-Cov-2 vaccine candidate moves ahead for animal trials

The four-week placebo-controlled, blinded and randomized tests to be conducted in mice will seek to evaluate safety and examine immune response dose titration in the rodent model................

COVID-19: Premas Biotech tries multi-antigenic approach to develop a vaccine

The triple antigen vaccine being developed by Premas Biotech is being designed to try to overcome presently known and possible future mutations of novel coronavirus...................

COVID-19: Premas Biotech & Akers Bio make significant progress on vaccine...

The partnership has announced that it has successfully obtained clones for all three selected Coronavirus antigens..................

Akers Bio partners Premas Biotech for COVID-19 vaccine candidate

Established D-Crypt™ platform will be used to develop a proof-of-concept targeting three of the top five viral vaccine protein candidates for Coronavirus